PRODUCT DESCRIPTION |
BULK DRUGS: DEXTROMETHORPHAN HYDROBROMIDE USP |
HOMATROPINE METHYL BROMIDE EP (B.NO.440502609003) |
THIOCOLCHICOSIDE (B.NO.077102711011) |
BROMHEXINE HCL BP |
THIOCOLCHICOSIDE (B.NO.077102711011) |
DEXTROMETHORPHAN HYDROBROMIDE USP-DTLS AS PER INVOICE |
THIOCOLCHICOSIDE (B.NO.077102711011) |
DEXTROMETHORPHAN HBR USP (GROUP-A /SRL NO:1177 |
DEXTROMETHORPHAN HBR BP/USP (GROUP-C/SLNO:1177 |
NICOTINE EP (B.NOS.469102711108 & 469102711109) |
PHARMACEUTICAL RAW MATERIAL DEXTROMETHORPHAN HYDROBROMIDE USP |
PENTOXIFYLLINE PH. EUR.(PENTOXIFYLLINE PH. EUR.) |
S7001-100G STRYCHNINE HEMISULFATE (0000002521) |
S7001-100G STRYCHNINE HEMISULFATE (BGBC5598V) |
BULK DRUGS: DEXTROMETHORPHAN HYDROBROMIDE USP |
BULK DRUGS: DEXTROMETHORPHAN HYDROBROMIDE USP |
BULK DRUGS: DEXTROMETHORPHAN HYDROBROMIDE USP |
DEXTROMETHORPHAN HBR USP/EP (GROUP-A /SRL NO:1177 |
THIOCOLCHICOSIDE FP BATCH NO. : 110530062016 MFG. DATE : OCT. 2016 EXP. DATE : SEP. 2021 (OTHER VEG ALKALOIDS NTRL OR RP |
BULK DRUGS: DEXTROMETHORPHAN HYDROBROMIDE USP |
BULK DRUGS: DEXTROMETHORPHAN HYDROBROMIDE EP |
TADALAFIL DC ORAL DISPERSIBLE GRANULES 8% W/W |
DEXTROMETHORPHAN HYDROBROMIDE (DEXTROMETHORPHAN HYDROBROMIDE BP 2014) (PHARMACEUTICAL RAW MATERIALS) |
INCLUDING REALIZATION OR REPATRIATION OFFOREIGN EXCHANGE TO OR FROM INDIA. |
WE INTEND TO CLAIM REWARDS UNDER MERCHANDISE EXPORTS FROM INDIA SCHEME (MEIS) |
I / WE UNDERTAKE TO ABIDE BY THE PROVISIONS OF FOREIGN EXCHANGE MANAGEMENT ACT,1999, AS AMENDED FROM TIME TO TIME, |
PENTOXIFYLLINE PH. EUR. (PENTOXIFYLLINEPH. EUR.) |
STRYCHNINE HCL CAPSULES |
NICOTINE 95% BATCH NO.: NI95103/16 TO NI95105/16 & NI95107/16 [WE INTEND TO CLAIM MEIS SCHEME] |
THIOCOLCHICOSIDE-B NO-M091600242DOM: SEPT.2016 DOE: AUG.2021B NO- M111600286 DOM:NOV.16 DOE:10/2020 |
DEXTROMETHORPHAN HBR USP/PH.EUR. (GROUP-B /SRL NO:1177 |
DEXTROMETHORPHAN HBR USP (GROUP-B/SL NO:1177 |
DEXTROMETHORPHAN HBR BP/USP (GROUP-B /SRL NO:1177 |
DEXTROMETHORPHAN HYDROBROMIDE BP |